Heart MRI may guide who needs a defibrillator early after a heart attack
NCT ID NCT03743935
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether an early heart MRI can help doctors know which patients with severe heart damage after a heart attack will get better on their own. The goal was to see if MRI could identify patients who would benefit from getting a defibrillator sooner rather than waiting the usual 40 days. The study was stopped early and included only 12 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
12 people
The number who actually took part.
- Started
-
Jan 2019
- Finished
-
Feb 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Acute STEMI within 5 last days with LVEF \< 35% * 18-80 years old * Admitted to the Cardiac ICU * Consent form Exclusion Criteria: * CABG surgery indicated * Contra-indications to MRI * ICD or PPM in place * Follow-up compromised
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute stemi are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Montpellier
Montpellier, 34090, France